Romano Brothers & Co’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDOC
AIM
NAMA
SOMRS
Romano Brothers & Co's TDOC Position: Q1 2023 in Review
Romano Brothers & Co sold out of Teladoc Health (TDOC) in Q1 2023, closing a stake of 358 shares — an estimated $8.47K sold.
Romano Brothers & Co first reported a position in TDOC in Q4 2022 and held it in 1 quarter. The position peaked at $8.47K in Q4 2022. 429 funds tracked by Wall St. Rank hold TDOC as of Q1 2023.
- Romano Brothers & Co reported no remaining Teladoc Health position as of Q1 2023 after selling out during the quarter.
- Romano Brothers & Co sold 358 Teladoc Health shares in Q1 2023, an estimated $8.47K.
- Romano Brothers & Co first reported a position in Teladoc Health in Q4 2022 and held it in 1 quarter.
- Romano Brothers & Co's Teladoc Health position peaked at $8.47K in Q4 2022.
- 429 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2023.
Based on Romano Brothers & Co's 13F filing for Q1 2023, filed 13 Apr 2023.